Holen Sie sich die Stockscreener-App
1.59
1.92%
0.03
Handel nachbörslich:
1.60
0.01
+0.63%
Schlusskurs vom Vortag:
$1.56
Offen:
$1.59
24-Stunden-Volumen:
46,784
Relative Volume:
0.14
Marktkapitalisierung:
$7.24M
Einnahmen:
$32.96M
Nettoeinkommen (Verlust:
$-4.23M
KGV:
-0.0102
EPS:
-155.3294
Netto-Cashflow:
$-14.00M
1W Leistung:
+5.44%
1M Leistung:
+10.42%
6M Leistung:
-44.98%
1J Leistung:
-74.15%
1-Tages-Spanne:
$1.54
$1.60
1-Wochen-Bereich:
$1.466
$1.6058
52-Wochen-Spanne:
$1.1693
$6.99
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Firmenname
Sunshine Biopharma Inc
Sektor
Telefon
954-515-0810
Adresse
333 LAS OLAS WAY, FORT LAUDERDALE
Vergleichen Sie SBFM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.59 | 6.87M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
What analysts say about Sunshine Biopharma Inc. Equity Warrant stockLightning-fast capital gains - jammulinksnews.com
What analysts say about Sunshine Biopharma Inc. stockAccelerated investment success - jammulinksnews.com
Is Sunshine Biopharma Inc. Equity Warrant a good long term investmentFree Risk Assessment Services - jammulinksnews.com
Sunshine Biopharma Inc. Equity Warrant Stock Analysis and ForecastUnstoppable investment returns - Autocar Professional
Sunshine Biopharma Inc. Stock Analysis and ForecastOutstanding capital growth - printweek.in
What drives Sunshine Biopharma Inc. Equity Warrant stock pricePowerful profit generation - jammulinksnews.com
Is Sunshine Biopharma Inc. a good long term investmentFree Stock Selection - jammulinksnews.com
What drives Sunshine Biopharma Inc. stock priceBreakout profit opportunities - jammulinksnews.com
Sunshine Biopharma (NASDAQ:SBFM) Downgraded by Wall Street Zen to Sell - Defense World
Why Sunshine Biopharma Inc. Equity Warrant stock attracts strong analyst attentionFree Access to Investment Community - Newser
How Sunshine Biopharma Inc. stock performs during market volatilityFast Moving Stock Alerts - Newser
What makes Sunshine Biopharma Inc. stock price move sharplyVolume Spike Monitors - Newser
How Sunshine Biopharma Inc. Equity Warrant stock performs during market volatilityFree Access to Community with 300% Return - Newser
What makes Sunshine Biopharma Inc. Equity Warrant stock price move sharplyRisk Adjusted Stock Signals - Newser
Why Sunshine Biopharma Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser
Sunshine Biopharma (SBFM) Stock Price, News & Analysis - MarketBeat
Sunshine Biopharma (NASDAQ:SBFM) Upgraded to “Hold” at Wall Street Zen - Defense World
Sunshine Biopharma (NASDAQ:SBFMW) Stock Price Down 12.6% – Here’s What Happened - Defense World
Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In - Stocktwits
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market - ACCESS Newswire
Sunshine Biopharma launches first biosimilar drug in Canadian market - Investing.com Australia
Sunshine Biopharma launches first biosimilar drug in Canadian market By Investing.com - Investing.com UK
Sunshine Biopharma Challenges $10B Biologics Market With New Cancer Treatment Biosimilar - Stock Titan
Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 3.8% – Here’s Why - Defense World
Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’ - MSN
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):